FDA Approves TUDORZA® PRESSAIR® (aclidinium bromide inhalation powder) Supplemental New Drug Application (sNDA) to include data for the Reduction of COPD Exacerbations and Hospitalizations | BioSpace
Which inhaler(s) do you use for Chronic Obstructive Pulmonary Disease (COPD)?